Eli Lilly and Company

Challenge: As one of the smaller companies in the competitive and sometimes-controversial pharmaceutical industry, candor and disclosure are keys to helping Eli Lilly and Company build and maintain trust with stakeholders.

BuzzWord Solution: BuzzWord has worked since 2005 to help Lilly develop and implement print-, pdf-, and web-based reporting strategies that build on its leadership in transparency on key industry practices. Most recently, for Lilly’s 2015 report, BuzzWord helped Lilly issue its first integrated report, kicking off the process by facilitating a workshop that brought together a range of internal stakeholders to map an effective transition. We also developed report content and an engaging communication piece to shareholders to accompany the company’s 2015 10K filing. Earlier, BuzzWord had developed strategy and content for Lilly’s first UN Global Compact Communication on Progress, which has been recognized as a model for other pharmaceutical firms.

GRI Status:

  • 2015 report GRI G4 referenced
  • 2012/13, 2010 and 2006/07 reports GRI G3 self-declared B-level
  • 2005/06 report used 2002 GRI Guidelines

Services:

  • Reporting strategy
  • Materiality analysis
  • Content development
  • GRI analysis

Subscribe to our mailing list

Note: BuzzWord will only use this information to provide the information requested and/or occasional updates via email. We will never share or sell your information to another organization.

* indicates required